I NSULIN-LIKE PEPTIDE 5 (INSL5), a member of the insulin superfamily, was first identified in human peripheral tissues including rectum, colon, and uterus and in murine thymus (1) . INSL5, a polypeptide of 135 amino acids, which are identical in the human and mouse, is characterized by a signal peptide, a B chain, an A chain, and a connecting C chain (1) , which is a signature motif of insulin-like molecules. In the initial report, INSL5 mRNA is reportedly absent in the mouse brain tissue or pituitary using the Northern blot (1) . More recently, quantitative RT-PCR study reveals the presence of INSL5 mRNA in a variety of human tissues including the brain, albeit in low levels, and the pituitary, which expresses a higher level of mRNA (2) . In the same study, INSL5 is identified as a specific ligand for the G protein-coupled receptor (GPCR) 142 to which it binds with a high affinity; INSL5 (up to 1 m) does not bind to several other GPCRs including LGR7, LGR8, and GPCR135 (2) . In functional assays, INSL5 mobilizes Ca 2ϩ in HEK293 cells transfected with GPCR142 and G␣ 16 expression constructs (2) . GPCR142 mRNA is expressed in several human tissues including colon, placenta, testis, thymus, prostate, kidney, and brain (2, 3) .
Here we report the detection of INSL5 mRNA and INSL5 immunoreactive neurons in the mouse brain as well as calcium mobilizing activity of INSL5 in dissociated and cultured mouse hypothalamic neurons.
Materials and Methods

Experimental animals
Adult male ICR mice (Ace Animal Inc., Boyertown, PA) were used, except in the series of experiments in which Ca 2ϩ measurements were made from dissociated and cultured mouse hypothalamic neurons harvested from 1-to 3-d postnatal mice. Experimental protocols were reviewed and approved by the Institutional Animal Care and Use Committee.
RT-PCR
Mice anesthetized with urethane (1.2 g/kg, ip) were decapitated with guillotine and the hypothalamus was dissected out. mRNA was purified using QuickPrep micro-mRNA purification kit (Amersham BioSciences, Piscataway, NJ) according to the manufacturer's instructions. Firststrand cDNA was synthesized using SuperScript III first-strand synthesis system for RT-PCR (Invitrogen, Carlsbad, CA). PCR was performed with a 5Ј primer (CCACTCTTGCTCTGTTTCTCCT) and a 3Ј primer (CTAACAGAGGGTGCTGAGTTCC) for INSL5, and a 5Ј primer (TCATGAAGTGTGACGTTGACATCCGT) and a 3Ј primer (CCTA-GAAGCATTTGCGGTGCACGATG) for ␤-actin under the following conditions: 94 C for 2 min; 32 cycles at 94 C for 30 sec, 55 C for 30 sec, and 72 C for 60 sec, and finally 72 C for 10 min. The amplified products were subjected to electrophoresis in a 1% agarose gel and stained with ethidium bromide. The DNA around 400 bp was purified using Qiaquick gel extraction kit (QIAGEN Inc., Valencia, CA) according to the manufacturer's instructions, and the DNA sequence was determined (DNA Sequencing Facility, University of Pennsylvania, Philadelphia, PA). 
Synthesis of mouse INSL5 (mINSL5) and production of antiserum
Immunohistochemistry
Mice were anesthetized with urethane (1.2 g/kg, ip) and intracardially perfused with 0.1 m PBS followed by freshly prepared 4% paraformaldehyde/0.2% picric acid in PBS. In single staining, tissues were processed for INSL5-immunoreactivity (irINSL5) by the avidin-biotin complex procedure (4) . Tissues were first treated with 3% H 2 O 2 to quench endogenous peroxidase, washed several times, and blocked with 10% normal goat serum, as described previously (4) . Tissues were then incubated in INSL5 antiserum for 48 h at 4 C with gentle agitation. The antiserum was used at a dilution of 1:1000 with 0.4% Triton X-100 and 1% BSA in PBS. After thorough rinsing, sections were incubated in biotinylated antirabbit IgG (1:150 dilution, Vector Laboratories, Burlingame, CA) for 2 h. Sections were rinsed with PBS and incubated in avidin-biotin complex solution for 1 h (1:100 dilution; Vector Laboratories). After several washes in Tris-buffered saline, sections were incubated in 0.05% diaminobenzidine/0.001% H 2 O 2 solution and washed for at least 2 h with Tris-buffered saline. Sections were mounted on slides with 0.25% gel alcohol, air dried, dehydrated with absolute alcohol followed by xylene, and coverslipped with Permount. To establish the specificity of INSL5 antiserum, hypothalamic sections were processed with INSL5 antiserum preabsorbed with the mINSL5 peptide (1 g/ml) overnight.
In the case of double labeling, the sequential labeling method with the primary antiserum from different hosts was used (4). Tissue sections were first labeled with INSL5 antiserum (1:750 dilution) and then with vasopressin-antiserum (1:1000 dilution, a guinea pig polyclonal from Bachem BioSciences Inc., King of Prussia, PA) or oxytocin-antiserum (1:1500 dilution, a mouse monoclonal from Chemicon, Temecula, CA). Sections were examined under a confocal scanning laser microscope (Leica TCS SL, Exton, PA) with excitation/emission wavelengths set to 488/520 nm for fluorescein isothiocyanate and 543/620 nm for Texas Red in the sequential mode.
Neuronal cell culture
Cells were isolated from the hypothalamus of postnatal 1-to 3-d-old ICR mice by enzymatic digestion with 0.5 mg papain per 100 mg tissue (5). Cells were plated at a density of 10 3 /mm 2 in a Neurobasal-A medium, supplemented with 10% fetal calf serum, 20 mm glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin (all from Invitrogen) and maintained at 37 C in a humidified atmosphere with 5% CO 2 . Glial cell growth was inhibited by the mitotic inhibitor cytosine ␤-arabino furanoside (1 m) (Sigma, St. Louis, MO). Neurons were cultured for 5 d. Cells were transferred to a medium without fetal serum 12 h before Ca 2ϩ measurements.
Measurement of cytosolic Ca 2ϩ concentrations
Cytosolic Ca 2ϩ concentrations [Ca 2ϩ ] i were measured by the microfluorimetric technique, as previously described (5) . Dissociated cells on coverslips were loaded with the fluorescent Ca 2ϩ indicator fura-2AM (3 m) by incubation of the cells in Hanks' balanced salt solution (HBSS) plus fura-2AM for 45 min and HBSS alone for an additional 15-60 min to allow deesterification of the dye. Coverslips were placed in a customdesigned bath and transferred to the stage of an inverted epifluorescence microscope (Nikon, Optical Apparatus Co. Inc., Ardmore, PA) equipped with a fluorometer system (C & L Instruments, Harrisburg, PA) (5). Cells were perfused with HBSS at a flow rate of 2.5 ml/min fura-2 fluorescence (excitation wavelength 340 and 380 nm, emission wavelength 520 nm) of single cells was acquired at a frequency of 1 Hz. The ratio of the fluorescence signals (340/380 nm) was converted to Ca 2ϩ concentrations (6) . For Ca 2ϩ -free experiments, HBSS without Ca 2ϩ supplemented with 1.5 mm EGTA was used. Neurons responding to INSL5 in a Ca 2ϩ -free medium were washed with regular HBSS for 1 h. Thereafter neurons were returned to a Ca 2ϩ -free medium and retested to a second administration of INSL5 in the absence or presence of thapsigargin, 2-aminoethoxydiphenyl borate (2-APB) or xestospongin C (XeC). During the washout period, cells were not subject to UV exposure.
Statistics
In calcium measurement experiments, statistical significance between groups was tested using one-way ANOVA followed by Bonferroni test, P Ͻ 0.05 being considered significantly different.
Results
RT-PCR
The primers for INSL5 flanked the sequence from the 11th to 408th nucleotide of INSL5 mRNA (NM_011831). The PCR product of INSL5 was 398 bp. INSL5 mRNA was present in the hypothalamus, albeit at a low level; ␤-actin mRNA was abundantly expressed in this region (Fig. 1) . DNA sequence result showed that there were two nucleotide differences, one a silent mutation and the other resulting in Gln45 instead of Arg45 reported in the protein sequence in NCBI protein database (AAD29687).
irINSL5 in the hypothalamus
Microscopic examination of tissue sections prepared from the brains and pituitary glands of six mice revealed irINSL5 cells in the hypothalamus (Fig. 2) and pituitary (Fig. 3) . The nomenclature of subdivisions of the hypothalamus follows that of Paxinos and Franklin (7) . Numerous irINSL5 cells were observed in the paraventricular, supraoptic, supraoptic retrochiasmatic, and accessory secretory nuclei throughout the rostrocaudal axis of the hypothalamus (Fig. 2) . Few ir-INSL5 cells were detected in the periventricular nucleus and lateral hypothalamic area (Fig. 2) . Within subdivisions of the hypothalamus, the majority of irINSL5 cells were noted in the lateral magnocellular part of the paraventricular nucleus and the supraoptic nucleus (Fig. 2, B and C) ; other subdivisions such as the posterior part of the paraventricular nucleus and the supraoptic retrochiasmatic nucleus expressed fewer irINSL5 cells (Fig. 2, E and F) . Numerous irINSL5 cell processes were seen emanating from the supraoptic (Fig. 2B) and paraventricular (Fig. 2C) a fairly dense layer of irINSL5 cell processes was detected in the internal layer of the median eminence (Fig. 2D) .
In control experiments, hypothalamic sections processed with INSL5 antiserum preabsorbed with the peptide (1 g/ ml) overnight showed no immunoreactivity.
INSL5 in the pituitary
INSL5 mRNA is highly expressed in the human pituitary (2). In the mouse posterior pituitary, irINSL5 was detected in varicosities and nerve terminal-like structures (Fig. 3A) . In the anterior pituitary, irINSL5 was present in a population of cells (Fig. 3B ).
Double labeling with INSL5 and vasopressin or oxytocin antiserum
Magnocellular neurons in the hypothalamus are either vasopressin-or oxytocin-containing neurons (8). Double-labeling experiments in which hypothalamic sections were labeled with INSL5 and vasopressin antiserum or INSL5 and oxytocin antiserum showed that nearly all irINSL5 cells were vasopressin-immunoreactive in the paraventricular hypothalamic nucleus (Fig. 4, A-C) ; not all vasopressin-immunoreactive neurons were irINSL5 in the supraoptic nucleus (Fig. 4, D-F) . Oxytocin-immunoreactive neurons were not irINSL5 in any of the sections examined and vice versa (Fig.  4, G-I) .
Mobilization of calcium in cultured hypothalamic neurons
The biological activity of INSL5 was evaluated by monitoring changes of [Ca 2ϩ ] i in cultured hypothalamic neurons. The basal [Ca 2ϩ ] i value of mouse dissociated hypothalamic neurons varied from 90 to 170 nm, which is in agreement with the concentration (30 -200 nm) reported in mammalian central neurons (9) .
In Ca 2ϩ -containing saline, INSL5 (100 nm), which is 10 times less than the concentration that produced maximal Ca 2ϩ mobilization in HEK293 cells (2) Fig. 5A . In another four cells, INSL5 induced a biphasic increase: a fast and transitory elevation of 237 Ϯ 4.7 nm followed by a slow and sustained increase of 249 Ϯ 6.1 nm (Fig. 5B) .
In the next series of experiments, the effects of INSL5 on dissociated hypothalamic neurons were studied in a Ca 2ϩ -free solution. In cells perfused with a Ca 2ϩ -free medium, INSL5 induced a transitory elevation of [Ca 2ϩ ] i of 179 Ϯ 3.5 nm (n ϭ 6). The mean [Ca 2ϩ ] i increase in Ca 2ϩ -free media was significantly (P Ͻ 0.05) smaller than that obtained in Ca 2ϩ -containing media. After 1 h wash in HBSS, cells were again perfused with a Ca 2ϩ -free saline. Under this condition, a second application of INSL5 induced an increase in [Ca 2ϩ ] i of 162 Ϯ 4.6 nm (n ϭ 6), which was not significantly different from the first response elicited in Ca 2ϩ -free media (Fig. 6 , A1 and A2). Pretreatment of the cells with 1 m thapsigargin (n ϭ 4) (Fig. 6, B2) , 100 m 2-APB (n ϭ 4) (Fig. 6, C2 ), or 5 m XeC (n ϭ 4) (Fig. 6, D2 ) abolished the second Ca 2ϩ response to INSL5.
Discussion
The insulin superfamily currently consists of several peptides of high structural but low sequence similarity. The family is composed of several relaxin/insulin-like peptides: relaxin-1, relaxin-2, relaxin-3/INSL7, INSL3, INSL4, INSL5, and INSL6 (2, 3, 10) .
In the present study, INSL5 mRNA was detected by RT-PCR in the mouse hypothalamus. Contrary to an abundance of ␤-actin mRNA, a low level of INSL5 transcript was detected in the hypothalamus of ICR mice. Determination of the cDNA sequence of ICR mice revealed two nucleotides that differ from the submitted murine cDNA sequence. The functional significance of this sequence variability is not clear. The difference may be the result of polymorphism of two nucleotides between the house mouse (Mus musculus) and the ICR mouse used in our study. Immunohistochemical studies using a polyclonal antiserum directed against the mINSL5 peptide revealed that irINSL5 is present in a discrete population of neurons in the mouse hypothalamus, corroborating the expression of INSL5 gene in the hypothalamus. The antiserum appears to be specific because preabsorption of the antiserum with the synthetic INSL5 peptide resulted in no positive labeling. Cell bodies immunoreactive to INSL5 are mainly confined to the hypothalamus including the supraoptic, paraventricular, and supraoptic retrochiasmatic nucleus; labeled somata are not observed in other areas of the mouse brain. Vasopressin and oxytocin synthesized in magnocellular neurons of the paraventricular and supraoptic nucleus are transported to the nerve endings and secreted into the blood capillary within the posterior pituitary gland. In this respect, irINSL5 is noted in cell processes emanating from neurons in the paraventricular and supraoptic nucleus, cell processes of the internal layer of the median eminence, and terminal-like endings of the posterior pituitary. Thus, INSL5 may be secreted into the blood capillary in a manner similar to that of vasopressin and oxytocin. Moreover, irINSL5 cells are noted in the anterior pituitary. At present, the type(s) of anterior pituitary cells expressing irINSL5 is not known. Magnocellular neurons in the paraventricular, supraoptic, and accessory secretory nucleus are either vasopressin-or oxytocin-containing neurons (8) . Double labeling the sections with INSL5 antiserum and vasopressin or oxytocin antiserum showed that irINSL5 cells are vasopressin but not oxytocin containing and that nearly all irINSL5 are vasopressin immunoreactive but not vice versa. The topographic distribution of irINSL5 in the hypothalamus and pituitary and its coexpression with vasopressin is similar to that of apelin, a 36-amino acid peptide proposed to be the endogenous ligand for the human orphan GPCR APJ (11, 12) . The biological activity of apelin has yet to be fully characterized. Several recent studies suggest that the peptide acting on APJ receptors may regulate diverse functions including fluid homeostasis, vascular reactivity, feeding behavior, and HIV infection (13) .
At the present time, information relative to the biological function of INSL5 is limited. A recent study has identified INSL5 as the endogenous ligand for the GPCR142 (2). Using fura-2 fluorescence as a functional assay, INSL5 increases [Ca 2ϩ ] i in dissociated mouse hypothalamic neurons. Approximately 10% of neurons sampled here responded to 100 nm INSL5. The relatively small number of responsive neurons appears to be in line with a low level of GPCR142 mRNA detected in the human brain (2) . Dissociated and cultured mouse hypothalamic neurons responded to INSL5 (100 nm) with two types of calcium responses. The fast and transitory response may be caused by activation of GPCR142, to which the peptide binds with a high affinity (2) . The second type of response, which consists of a fast and transitory elevation followed by a prolonged increase, may correspond, respectively, to the activation of GPCR142 and possibly of another receptor(s) by a bioactive substance(s) released secondarily from adjacent neurons.
Transient increases in intracellular calcium result from an influx of calcium through plasmalemmal voltage-or ligandgated calcium channels and/or release from internal stores (14) . (2) . Many neuronal processes, including differentiation, neurite outgrowth, and apoptosis, are Ca 2ϩ mediated. In mammalian central neurons, the Ca 2ϩ set point that switches between neurite outgrowth and growth cone collapse, is approximately 1000 nm (9) . Viewed in this context, INSL5 induces a moderate increase in [Ca 2ϩ ] i , which is in the range that may induce neurite outgrowth and/or axonal branching in targeted neurons (19) . Moreover, it is well documented that synaptic transmission is critically dependent on [Ca 2ϩ ] i (20) . The elevation of [Ca 2ϩ ] i produced by INSL5 may lead to changes in membrane excitability and/or enhancement in neurosecretion of target neurons. In summary, our results demonstrate for the first time the presence of INSL5 in mouse hypothalamic neurons, principally in vasopressin-containing neurons and the pituitary gland, and the peptide stimulates Ca 2ϩ influx and Ca 2ϩ release from IP 3 -sensitive stores in mouse cultured hypothalamic neurons.
